These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cervical adenocarcinoma in young women: possible relationship to microglandular hyperplasia and use of oral contraceptives. Jones MW, Silverberg SG. Obstet Gynecol; 1989 Jun 01; 73(6):984-9. PubMed ID: 2726119 [Abstract] [Full Text] [Related]
3. Comparison of oral contraceptive use in women with adenocarcinoma and squamous cell carcinoma of the uterine cervix. Honoré LH, Koch M, Brown LB. Gynecol Obstet Invest; 1991 Jun 01; 32(2):98-101. PubMed ID: 1748331 [Abstract] [Full Text] [Related]
5. [Adenocarcinoma of the cervix and the use of oral contraceptives]. Dtsch Med Wochenschr; 1995 Sep 29; 120(39):1341. PubMed ID: 7555649 [No Abstract] [Full Text] [Related]
8. Pathogenesis of microglandular hyperplasia of the cervix uteri. Wilkinson E, Dufour DR. Obstet Gynecol; 1976 Feb 29; 47(2):189-95. PubMed ID: 1250541 [Abstract] [Full Text] [Related]
9. [Topics in histopathological diagnosis of cancer of the uterine cervix]. Tsuda H. Nihon Rinsho; 2004 Oct 29; 62 Suppl 10():119-22. PubMed ID: 15535218 [No Abstract] [Full Text] [Related]
11. Carcinoma of the cervix and oral contraceptives: epidemiological studies. Vessey M, Grice D. Biomed Pharmacother; 1989 Oct 29; 43(3):157-60. PubMed ID: 2673422 [Abstract] [Full Text] [Related]
18. [Adenocarcinoma of the uterine cervix in patients using hormonal contraceptives]. Erbstösser E, Nieder J, Adomat K. Zentralbl Gynakol; 1989 Oct 29; 111(11):736-43. PubMed ID: 2781887 [Abstract] [Full Text] [Related]